Journal Title：International Clinical Psychopharmacology

International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.

A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.

《國(guó)際臨床精神藥理學(xué)》在整個(gè)精神藥理學(xué)領(lǐng)域?yàn)檠芯颗c臨床實(shí)踐提供了重要聯(lián)系。它報(bào)道了對(duì)人類(lèi)受試者（包括健康志愿者和患者）的研究，這些研究將藥物對(duì)心理過(guò)程的影響聯(lián)系起來(lái)。

該期刊的主要目標(biāo)是發(fā)表經(jīng)過(guò)全面審查的論文，闡明精神藥物研究如何增進(jìn)我們對(duì)精神藥理學(xué)的了解。為此，該期刊發(fā)表了早期 I 期和 II 期研究的結(jié)果，以及 II 期和 IV 期精神藥物對(duì)照臨床試驗(yàn)的結(jié)果。其他主題包括精神藥物處方和服藥的流行病學(xué)、精神藥物的社會(huì)學(xué)（包括依從性）以及對(duì)這些化合物的安全性和不良反應(yīng)的研究。

International Clinical Psychopharmacology創(chuàng)刊于1986年，由Lippincott Williams and Wilkins Ltd.出版商出版，收稿方向涵蓋醫(yī)學(xué) - 精神病學(xué)全領(lǐng)域，此刊是中等級(jí)別的SCI期刊，所以過(guò)審相對(duì)來(lái)講不是特別難，但是該刊專(zhuān)業(yè)認(rèn)可度不錯(cuò)，仍然是一本值得選擇的SCI期刊 。平均審稿速度 12周，或約稿 ，影響因子指數(shù)2.1，該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單，廣大學(xué)者值得一試。